These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1007153)

  • 1. The Côté serum (anti-K11), an antibody defining a new variant in the Kell system.
    Guévin RM; Taliano V; Waldmann O
    Vox Sang; 1976; 31(1 SUPPL):96-100. PubMed ID: 1007153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel common Kell antigen, TOU, and its spatial relationship to other Kell antigens.
    Jones J; Reid ME; Oyen R; Harris T; Moscarelli S; Co S; Leger R; Beal C; Cardillo K
    Vox Sang; 1995; 69(1):53-60. PubMed ID: 7483493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Another Kell-related antibody, anti-K19.
    Sabo B; McCreary J; Stroup M; Smith DE; Weidner JG
    Vox Sang; 1979; 36(2):97-102. PubMed ID: 462900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of K11 and K17 as alleles in the Kell blood group system.
    Sabo B; McCreary J; Gellerman M; Stroup M; Neale SP; Bell CB
    Vox Sang; 1975; 29(6):450-5. PubMed ID: 1210229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI.
    Velliquette RW; Hue-Roye K; Lomas-Francis C; Gillen B; Schierts J; Gentzkow K; Peyrard T; von Zabern I; Flegel WA; Rodberg K; Debnath AK; Lee S; Reid ME
    Transfusion; 2013 Nov; 53(11 Suppl 2):2872-81. PubMed ID: 23560718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual suppression of Kell system antigens in a healthy blood donor.
    Norman PC; Daniels GL
    Transfusion; 1988; 28(5):460-2. PubMed ID: 3420674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.
    Lomas-Francis C; Vege S; Velliquette RW; Fuchisawa A; Uchikawa M; Tani Y; Moro H; Debnath AK; Westhoff CM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2887-91. PubMed ID: 23968329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another example of mimicking anti-Kpb in a Kp(a+b-) patient.
    Puig N; Carbonell F; Marty ML
    Vox Sang; 1986; 51(1):57-9. PubMed ID: 3739324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed hemolytic transfusion reaction caused by the second example of anti-K19.
    Marsh WL; DiNapoli J; Oyen R; Greenspan R; Hu A; Rincon F
    Transfusion; 1979; 19(5):604-8. PubMed ID: 505537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A further example of Kp1/Ko exhibiting depression of some Kell group antigens.
    Ford DS; Knight AE; Smith F
    Vox Sang; 1977; 32(4):220-3. PubMed ID: 855255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K23. A low-incidence antigen in the Kell blood group system identified by biochemical characterization.
    Marsh WL; Redman CM; Kessler LA; DiNapoli J; Scarborough AL; Philipps AG; Mody KM
    Transfusion; 1987; 27(1):36-40. PubMed ID: 3810821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a).
    Tuson M; Hue-Roye K; Koval K; Imlay S; Desai R; Garg G; Kazem E; Stockman D; Hamilton J; Reid ME
    Immunohematology; 2011; 27(2):58-60. PubMed ID: 22356520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematological changes associated with the McLeod phenotype of the Kell blood group system.
    Wimer BM; Marsh WL; Taswell HF; Galey WR
    Br J Haematol; 1977 Jun; 36(2):219-24. PubMed ID: 871435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Ko phenotype and fetal-maternal allo-immunization].
    Fourmaintraux A; Vitrac D; Mariette JB; Brunel F
    Arch Fr Pediatr; 1993 Nov; 50(9):779-81. PubMed ID: 8060208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hemolytic anemia and the Kell blood groups.
    Marsh WL; Oyen R; Alicea E; Linter M; Horton S
    Am J Hematol; 1979; 7(2):155-62. PubMed ID: 539592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autoanti-Kp b immunoglobulin M that simulates antigen suppression.
    Bosco A; Xenocostas A; Kinney J; Cadwell CM; Zimring JC
    Transfusion; 2009 Apr; 49(4):750-6. PubMed ID: 19170996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system.
    Symmans WA; Shepherd CS; Marsh WL; Oyen R; Shohet SB; Linehan BJ
    Br J Haematol; 1979 Aug; 42(4):575-83. PubMed ID: 476009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity and the Kell blood groups: auto-anti-Kpb in a Kp(a+b-) patient.
    Manny N; Levene C; Sela R; Johnson CL; Mueller KA; Marsh WL
    Vox Sang; 1983; 45(3):252-6. PubMed ID: 6624011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-K12 in the serum of two brothers: inheritance of the K:-12 phenotype.
    Beattie KM; Heinz B; Korol S; Oyen R; Marsh WL
    Rev Fr Transfus Immunohematol; 1982 Dec; 25(6):611-8. PubMed ID: 7170567
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration by the monoclonal antibody-specific immobilization of erythrocyte antigens assay that a new red cell antigen belongs to the Kell blood group system.
    Daniels GL; Petty AC; Reid M; Moulds M; Devenish A; Halil O
    Transfusion; 1994 Sep; 34(9):818-20. PubMed ID: 8091473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.